22nd Century Group Inc (NYSEAMERICAN:XXII) shot up 8.5% during mid-day trading on Wednesday . The company traded as high as $2.06 and last traded at $2.04. 1,397,600 shares changed hands during trading, a decline of 22% from the average session volume of 1,783,796 shares. The stock had previously closed at $1.88.
A number of brokerages have issued reports on XXII. Chardan Capital reissued a “buy” rating and set a $11.50 target price on shares of 22nd Century Group in a research note on Wednesday, May 8th. TheStreet lowered shares of 22nd Century Group from a “c-” rating to a “d+” rating in a research note on Friday, March 29th.
22nd Century Group (NYSEAMERICAN:XXII) last issued its earnings results on Tuesday, May 7th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $6.29 million for the quarter.
Several large investors have recently modified their holdings of the business. Mercer Global Advisors Inc. ADV acquired a new stake in shares of 22nd Century Group in the 1st quarter valued at $28,000. Raymond James Financial Services Advisors Inc. lifted its stake in shares of 22nd Century Group by 52.6% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 18,348 shares of the biotechnology company’s stock valued at $31,000 after purchasing an additional 6,323 shares during the last quarter. HRT Financial LLC acquired a new stake in shares of 22nd Century Group in the 4th quarter valued at $33,000. D. E. Shaw & Co. Inc. acquired a new stake in shares of 22nd Century Group in the 4th quarter valued at $33,000. Finally, GSA Capital Partners LLP acquired a new stake in shares of 22nd Century Group in the 4th quarter valued at $38,000.
COPYRIGHT VIOLATION WARNING: “22nd Century Group (XXII) Shares Up 8.5%” was first reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://transcriptdaily.com/2019/05/16/22nd-century-group-xxii-shares-up-8-5.html.
About 22nd Century Group (NYSEAMERICAN:XXII)
22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies.
Further Reading: What is a Lock-Up Period?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.